CIK: 1738054 - Address: C/O Amneal Pharmaceuticals, Inc., 400 Crossing Boulevard, Bridgewater, NJ 08807
10 results

TC

Stat

Stk

Ins

Fil

+d

+w

+m

+q

+h

+y

avg

Filing Date

T Date

Ticker

Issuer

Inc

Sector

Ind

Industry

Owner

oSt

Rel

Title

T

TVal

Price

L

Qty

oc

Own

H

r2y

r1y

r6m

r3m

r6w

r3w

r7d

r3d

f1d

f1w

f1m

f3m

f6m

f1y
1/10/25 16:25
1/8/25
AMRXAmneal Pharmaceuticals, Inc.HealthDrugPharmaceutical PreparationsPatel GautamNJDS-5018.010-63-31,969D
1/6/25 16:22
1/2/25
AMRXAmneal Pharmaceuticals, Inc.HealthDrugPharmaceutical PreparationsPatel GautamNJDS-1398.010-17-12,031D
5/14/24 16:38
5/10/24
AMRXAmneal Pharmaceuticals, Inc.HealthDrugPharmaceutical PreparationsPatel GautamNJDM.d00.0007642,049D
5/11/23 16:15
5/10/23
AMRXAmneal Pharmaceuticals, Inc.HealthDrugPharmaceutical PreparationsPatel GautamNJDM.d00.00080113,262D
5/10/22 19:04
5/8/22
AMRXAmneal Pharmaceuticals, Inc.HealthDrugPharmaceutical PreparationsPatel GautamNJDM.d00.00035013,182D
12/20/21 18:49
12/17/21
AMRXAmneal Pharmaceuticals, Inc.HealthDrugPharmaceutical PreparationsPatel GautamNJDP2114.21050013,146D
5/7/21 14:09
5/6/21
AMRXAmneal Pharmaceuticals, Inc.HealthDrugPharmaceutical PreparationsPatel GautamNJDM.d00.00046013,096D
5/7/20 17:23
5/7/20
AMRXAmneal Pharmaceuticals, Inc.HealthDrugPharmaceutical PreparationsPatel GautamNYDTM.d00.0006013,050D
3/10/20 21:14
3/2/20
AMRXAmneal Pharmaceuticals, Inc.HealthDrugPharmaceutical PreparationsPatel GautamNYDTP.m5893.930150113,044D
5/8/19 17:49
5/8/19
AMRXAmneal Pharmaceuticals, Inc.HealthDrugPharmaceutical PreparationsPatel GautamNYDTM.d00.0006New6D

DDerivative transaction in filing (usually option exercise)
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
AAmended filing
EError detected in filing
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top

Contact